103 related articles for article (PubMed ID: 24597770)
1. Prevalence of human polyomavirus DNA in eyebrow hairs plucked from patients with psoriasis treated with TNF inhibitors.
Bellaud G; Gheit T; Pugin A; Prétet JL; Tommasino M; Mougin C; Aubin F
J Eur Acad Dermatol Venereol; 2015 May; 29(5):1019-21. PubMed ID: 24597770
[No Abstract] [Full Text] [Related]
2. Prevalence of human Papillomavirus DNA in eyebrow hairs plucked from patients with psoriasis treated with TNF inhibitors.
Bellaud G; Gheit T; Pugin A; Prétet JL; Tommasino M; Mougin C; Aubin F
J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1816-20. PubMed ID: 24206262
[TBL] [Abstract][Full Text] [Related]
3. Elevation of serum KL-6 in patients with psoriasis treated with anti-tumour necrosis factor-α therapy.
Higashi Y; Tada K; Shimokawa M; Kawai K; Kanekura T
Clin Exp Dermatol; 2016 Jan; 41(1):88-90. PubMed ID: 25557847
[TBL] [Abstract][Full Text] [Related]
4. From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis.
Motaparthi K; Stanisic V; Van Voorhees AS; Lebwohl MG; Hsu S;
J Am Acad Dermatol; 2014 Jan; 70(1):178-86. PubMed ID: 24220724
[TBL] [Abstract][Full Text] [Related]
5. Reactivation of human polyomavirus JC in patients affected by psoriasis vulgaris and psoriatic arthritis and treated with biological drugs: preliminary results.
Nardis C; Anzivino E; Bellizzi A; Rodio DM; De Pità O; Chiarini F; Pietropaolo V
J Cell Physiol; 2012 Dec; 227(12):3796-802. PubMed ID: 22422468
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with tumor necrosis factor inhibitors in psoriasis treatment.
Famenini S; Wu JJ
Cutis; 2013 Sep; 92(3):140-7. PubMed ID: 24153143
[TBL] [Abstract][Full Text] [Related]
7. Low-dose methotrexate - a therapeutical kick in TNF-alpha antagonist treatment for recalcitrant psoriasis vulgaris.
Wilsmann-Theis D; Fronhoffs K; Ehler LK; Wenzel J; Bieber T; Klingmueller K
Dermatol Ther; 2014; 27(1):55-9. PubMed ID: 24502314
[TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of human papillomavirus in hairs plucked from patients with psoriasis treated with psoralen-UV-A.
Wolf P; Seidl H; Bäck B; Binder B; Höfler G; Quehenberger F; Hoffmann C; Kerl H; Stark S; Pfister HJ; Fuchs PG
Arch Dermatol; 2004 Mar; 140(3):317-24. PubMed ID: 15023775
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous histoplasmosis as a complication after anti-TNF use--Case report.
Zattar GA; Cardoso F; Nakandakari S; Soares CT
An Bras Dermatol; 2015; 90(3 Suppl 1):104-7. PubMed ID: 26312688
[TBL] [Abstract][Full Text] [Related]
10. Effective and sustainable biologic treatment of psoriasis: what can we learn from new clinical data?
Langley RG
J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():21-9. PubMed ID: 22356632
[TBL] [Abstract][Full Text] [Related]
11. Distribution of human papillomavirus genotypes in plucked eyebrow hairs from Slovenian males with genital warts.
Kocjan BJ; Poljak M; Seme K; Potocnik M; Fujs K; Babic DZ
Infect Genet Evol; 2005 Apr; 5(3):255-9. PubMed ID: 15737917
[TBL] [Abstract][Full Text] [Related]
12. Etanercept in psoriasis treatment.
Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989
[TBL] [Abstract][Full Text] [Related]
13. Effects of anti-TNF-α agents on circulating endothelial-derived and platelet-derived microparticles in psoriasis.
Pelletier F; Garnache-Ottou F; Biichlé S; Vivot A; Humbert P; Saas P; Seillès E; Aubin F
Exp Dermatol; 2014 Dec; 23(12):924-5. PubMed ID: 25255926
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.
Gisondi P; Cotena C; Tessari G; Girolomoni G
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):341-4. PubMed ID: 18005022
[TBL] [Abstract][Full Text] [Related]
15. Analysis of human β-papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of patients with chronic lymphocytic leukaemia.
Peretti A; Borgogna C; Rossi D; De Paoli L; Bawadekar M; Zavattaro E; Boldorini R; De Andrea M; Gaidano G; Gariglio M
Br J Dermatol; 2014 Dec; 171(6):1525-8. PubMed ID: 24976446
[TBL] [Abstract][Full Text] [Related]
16. Sustained effects of low dose infliximab in combination with methotrexate in the management of chronic recalcitrant psoriasis.
Zargari O
Dermatol Online J; 2005 Dec; 11(3):21. PubMed ID: 16409917
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis.
Paul C; Le Tourneau A; Cayuela JM; Devidas A; Robert C; Molinié V; Dubertret L
Arch Dermatol; 1997 Jul; 133(7):867-71. PubMed ID: 9236525
[TBL] [Abstract][Full Text] [Related]
18. Persistence of Staphylococcus aureus colonization among individuals with immune-mediated inflammatory diseases treated with TNF-α inhibitor therapy.
Varley CD; Deodhar AA; Ehst BD; Bakke A; Blauvelt A; Vega R; Yamashita S; Winthrop KL
Rheumatology (Oxford); 2014 Feb; 53(2):332-7. PubMed ID: 24173434
[TBL] [Abstract][Full Text] [Related]
19. [Prescription and surveillance of treatment by a systemic agent or biotherapy in psoriasis].
Boulinguez S
Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):8-12. PubMed ID: 20510169
[No Abstract] [Full Text] [Related]
20. Etanercept combined with methotrexate for high-need psoriasis.
Driessen RJ; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2008 Aug; 159(2):460-3. PubMed ID: 18547310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
